Fed. Circ. Decision Offers Lessons In Analogous Art Tests
The recent Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals Inc. decision reminds petitioners in inter partes reviews of the importance of sufficiently addressing a long-standing threshold issue that seems to have been...To view the full article, register now.
Already a subscriber? Click here to view full article